Hey Kevin, Thanks for your thoughts. I had a different take on the outcome measurement, mostly that the Aminyire outcome was very practical (I think I gave it a 5). They were evaluating a tool to streamline implementation, not to measure virologic suppression (which was the outcome that was evaluated in the Rosen study). The impact of early ART initiation on virologic outcomes and mortality has already been evaluated in prior studies.